ruvonoflast   Click here for help

GtoPdb Ligand ID: 13008

Synonyms: NT-0796 | NT0796
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Ruvonoflast (NT-0796; Rezera, formerly NodThera) is an orally bioactive, selective, and brain-penetrant small-molecule inhibitor of NLRP3 inflammasome activity [1]. The anti-inflammatory action of ruvonoflast was proposed as a mechanism to reduce atherosclerotic cardiovascular risk [2], and potentially neuroinflammation.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 9
Topological polar surface area 89.35
Molecular weight 409.48
XLogP 1.92
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)OC(=O)[C@@H](CC1=NC=CC=N1)OC(=O)NC2=C3CCCC3=CC4=C2CCC4
Isomeric SMILES C1CCC2=C(C=3CCCC3C=C12)NC(=O)O[C@@H](C(=O)OC(C)C)CC4=NC=CC=N4
InChI InChI=1S/C23H27N3O4/c1-14(2)29-22(27)19(13-20-24-10-5-11-25-20)30-23(28)26-21-17-8-3-6-15(17)12-16-7-4-9-18(16)21/h5,10-12,14,19H,3-4,6-9,13H2,1-2H3,(H,26,28)/t19-/m1/s1
InChI Key UMUQEMHROZVOTF-LJQANCHMSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Harrison D, Billinton A, Bock MG, Doedens JR, Gabel CA, Holloway MK, Porter RA, Reader V, Scanlon J, Schooley K et al.. (2023)
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders.
J Med Chem, 66 (21): 14897-14911. [PMID:37874905]
2. Ray KK, Clarke N, Thornton P, Miles AE, Digby Z, Davies MJ, Gorman M, Mullen B, Reader V, Magill M et al.. (2026)
Anti-Inflammatory Effects of Oral NLRP3 Inhibition With Ruvonoflast Among Individuals at Elevated Cardiovascular Risk.
J Am Coll Cardiol, 88 (17): 1981-1994. [PMID:42187339]